PW Medtech Group Ltd. (HK:1358) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
PW Medtech Group Ltd. plans a major transaction involving the proposed spin-off of its subsidiary Sichuan Ruijian Medical, which is set to proceed with a subsequent listing on the Beijing Stock Exchange. The listing will involve issuing new shares, with the process expected to progress by the end of the first quarter of 2025, depending on regulatory approvals and market conditions. This move is aimed at enhancing the subsidiary’s market presence while retaining its status as a subsidiary of PW Medtech.
For further insights into HK:1358 stock, check out TipRanks’ Stock Analysis page.
